Since the distribution of C1q deposition was similar than that of IgG, C4, and C3 in all cases (Figure 1 and Figure 2 and Table 3), we concluded that the classical pathway is a common route of C activation in the lungs of our COVID-19 patients. Here, C4A is linked to COVID-19.